Home / Inspections / 1100047

FDA Inspection 1100047 — Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. — FEI 3002936358

The FDA completed an inspection of Amphastar Pharmaceuticals, Inc. on July 25, 2019 in Rancho Cucamonga, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rancho Cucamonga, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1266798 (NAI Thu Apr 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229403 (VAI Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1144508 (NAI Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113865 (NAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115634 (NAI Thu Nov 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources